Director/PDMR Shareholding
Cambridge Nutritional Sciences plc announced that its Non-Executive Chair, Carolyn Rand, purchased 150,000 ordinary shares at an average price of 2.32 pence each, increasing her total beneficial holding to 347,500 shares, representing 0.14% of the issued share capital. Additionally, Non-Executive Director Jeremy Millard acquired 168,776 ordinary shares at 2.37 pence each, bringing his total beneficial holding to 1,193,776 shares, or 0.50% of the issued share capital. These director share purchases indicate confidence in the company's prospects.
Select text to share a quote on X · sign in to keep highlights & notes in your CNSL notes
CNS (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces that it has received notification that Carolyn Rand, Non-Executive Chair of the Company, has purchased 150,000 ordinary shares of 4 pence each in the Company ("Ordinary Shares"), at an average price of 2.32 pence each. Jeremy Millard, Non-Executive Director of the Company, has also purchased 168,776 Ordinary Shares in the Company, at a price of 2.37 pence each.
A summary of Carolyn Rand and Jeremy Millard's resultant holdings is below:
| Director | Board Position | Number of Ordinary Shares acquired | Total beneficial holding of Ordinary Shares following this acquisition | |||||||
| Number of Ordinary Shares | Approximate % of Company's issued share capital | |||||||||
| Carolyn Rand | Non-Executive Chair | 150,000 | 347,500 | 0.14% | ||||||
| Jeremy Millard | Non-Executive Director | 168,776 | 1,193,776 | 0.50% | ||||||
| a) | Name | Carolyn Rand | ||||||||
| 2 | Reason for the notification | |||||||||
| a) | Position/status | Non-Executive Chair | ||||||||
| b) | Initial notification /Amendment | Initial Notification | ||||||||
| a) | Name | Cambridge Nutritional Sciences plc | ||||||||
| b) | LEI | 2138007U9P4BTZTYIR92 | ||||||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of 4 pence each ISIN: GB00B1VCP282 | ||||||||
| b) | Nature of the transaction | Ordinary Shares purchased | ||||||||
| c) | Price(s) and volume(s) |
| ||||||||
| d) | Aggregated information -Aggregated volume - Price | Aggregated volume - 150,000 Price - 2.3216 | ||||||||
| e) | Date of the transaction | 18.11.2025 | ||||||||
| f) | Place of the transaction | London Stock Exchange | ||||||||
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||||||
| a) | Name | Jeremy Millard | ||||||||
| 2 | Reason for the notification | |||||||||
| a) | Position/status | Non-Executive Director | ||||||||
| b) | Initial notification /Amendment | Initial Notification | ||||||||
| a) | Name | Cambridge Nutritional Sciences plc | ||||||||
| b) | LEI | 2138007U9P4BTZTYIR92 | ||||||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of 4 pence each ISIN: GB00B1VCP282 | ||||||||
| b) | Nature of the transaction | Ordinary Shares purchased | ||||||||
| c) | Price(s) and volume(s) |
| ||||||||
| d) | Aggregated information -Aggregated volume - Price | As above. | ||||||||
| e) | Date of the transaction | 18.11.2025 | ||||||||
| f) | Place of the transaction | London Stock Exchange |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.